Showing results (21-30 of 153) with videos related to
Sort By:
Pageof 16
Cancer Journal (Sudbury, Mass.)|January 25, 2020
Pathologically Node-Positive Prostate Cancer: Casting for Cure When the Die Is Cast?Kevin B Ginsburg, Michael L Cher, Alexander Kutikov, et al.Cytometry|July 1, 1997
A t-statistic for objective interpretation of comparative genomic hybridization (CGH) profilesD H Moore, M Pallavicini, M L Cher, et al.BJU International|July 5, 2011
Primary full-gland prostate cryoablation in older men (> age of 75 years): results from 860 patients tracked with the COLD RegistryNivedita Dhar, John F Ward, Michael L Cher, et al.Urologic Oncology|December 12, 2002
Presence of circulating prostate cancer cells in African American males adversely affects survivalFernando J Bianco, Isaac J Powell, Michael L Cher, et al.Clinical & Experimental Metastasis|April 21, 2001
Persistence of human vascular endothelium in experimental human prostate cancer bone tumorsJ A Nemeth, J W Roberts, C M Mullins, et al.Journal of Neuro-Oncology|December 1, 1996
Therapy of primary central nervous system lymphoma with pre-irradiation methotrexate, cyclophosphamide, doxorubicin, vincristine, and dexamethasone (MCHOD)J Glass, C Shustik, F H Hochberg, et al.Clinical & Experimental Metastasis|May 1, 1996
Identification of genetic alterations associated with the process of human experimental colon cancer liver metastasis in the nude mouseT J Yeatman, M L Cher, W Mao, et al.Water Science and Technology : a Journal of the International Association on Water Pollution Research|January 18, 2014
Comparison of two standard odor intensity evaluation methods for odor problems in air or waterJane Curren, Cherie L Cher Snyder, Samantha Abraham, et al.BMJ Open|February 22, 2022
Five-year follow-up study of a population-based prospective cohort of men with low-risk prostate cancer: the treatment options in prostate cancer study (TOPCS): study protocolJinping Xu, Michael Goodman, James Janisse, et al.The Journal of Urology|May 1, 1996
Cellular proliferative fraction of metastatic lymph nodes predicts survival in stage D1 (TxN+M0) prostate cancerM L Cher, R A Stephenson, B C James, et al.Pageof 16